Trial intelligence / Profile preview

Darvadstrocel for complex perianal fistulas in Japanese CD patients

NCT03706456Phase 3Completed

Sponsor
Takeda
Start
Mar 2019
Primary completion
Jul 2020
Modality
Stem Cell Therapies
Countries
1
01

Overview

A Phase 3 trial of darvadstrocel in Crohn's disease, sponsored by Takeda. Started Mar 2019; status: completed.

02

Drugs

darvadstrocel
03

Conditions

Crohn's disease

Beyond the preview

Go deeper on NCT03706456.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03706456.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call